Faeth Therapeutics, Inc. (FTH)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Faeth Therapeutics, Inc.’s filings yet. We add companies and filings all the time.
Track FTH and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | Aug 14, 2026 | $26.05M |
| FRANKLIN RESOURCES INC | Aug 13, 2026 | $12.36M |
| GEODE CAPITAL MANAGEMENT, LLC | Nov 6, 2026 | $6.9M |
| MARSHALL WACE, LLP | Aug 13, 2026 | $5.16M |
| MILLENNIUM MANAGEMENT LLC | May 15, 2026 | $4.62M |
FTH's filings are public. The insight is one click away.
Scrutar's AI reads every FTH filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a FTH filing.
Get an email when FTH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.